Use of olanzapine in non-psychotic psychiatric disorders

By Goodnick P.J.   Barrios C.A.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 667-680

Informa Healthcare

Access to resources Recommend Favorite

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

By Bonuccelli Ubaldo   Meco Giuseppe   Fabbrini Giovanni   Tessitore Alessandro   Pierantozzi Mariangela   Stocchi Fabrizio   Ceravolo Roberto   Caltagirone Carlo   Silvestrini Mauro   Morgante Francesca   Ruggieri Stefano   Avanzino Laura   Guadagna Michele   Dell'Agnello Grazia   Rossi Andrea   Spezia Riccardo   Mancini Michele  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2269-2280

Informa Healthcare

Access to resources Recommend Favorite

Practitioner Pointer: Eliciting Psychotic Symptoms in Depressed Adolescents

By  

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 3, 2002-06 ,pp. : 6-6

Guilford Publications Inc

Access to resources Recommend Favorite

One Hundred Faces of Cyclopamine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 12, 2016-04 ,pp. : 1658-1681

Bentham Science Publishers

Access to resources Recommend Favorite

Getting Better, Getting Well: Understanding and Managing Partial and Non-Response to Pharmacological Treatment of Non-Psychotic Major Depression in Old Age

By Driscoll Henry C.   Karp Jordan F.   Mary Amanda Dew   Reynolds Charles F.  

Drugs & Aging, Vol. 24, Iss. 10, 2007-01 ,pp. : 801-814

Adis International

Access to resources Recommend Favorite